Convalescent Plasma Futile as Treatment for Critically Ill COVID-19 Patients
In the earliest days of the COVID-19 pandemic, the medical community turned to a century-old treatment: Take blood from...
medicine focused on developing and delivering
therapies that reestablish tissue and organ function
impaired by disease, trauma or congenital abnormalities.
GENE THERAPY
Phase I Clinical Trial Next Step
TRANSPLANTATION
Mimicking Cancer to Avoid Transplant Rejection
Introduction to The McGowan Institute
To provide a national center of expertise in regenerative medicine.
Watch Our Video
Research Spotlight
UPMC-Pitt Researchers Receive Grant to Advance Liver Organoids.
Read more
Featured News
Using AI to Treat Acute Kidney Injuries
Among critically ill patients with acute kidney injury and treated with dialysis in the intensive care unit, if one...
Podcast: Cardiovascular Services with Mr. Stephen Winowich
Procirca is a clinical healthcare services business focused on cardiovascular surgery, clinical neurophysiology, perioperative blood management, and clinical engineering....
New Material Aids in Neural Stimulation
The ability to target and stimulate neurons brings a host of benefits including better understanding brain function and treating...
Video: Hope vs. Hype of Stem Cell Therapy
